We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PL
776
DELISTED
PROTECTIVE LIFE CORP
PL
| $210K | ﹤0.01% |
+3,992
| New | +$205K |
|
777
Manulife Financial
MFC
$73.9B
| $209K | ﹤0.01% |
+10,800
| New | +$207K |
|
|
CSC
778
DELISTED
Computer Sciences
CSC
| $209K | ﹤0.01% |
8,123
-18,943
| -70% | -$476K |
|
779
Bristol-Myers Squibb
BMY
$133B
| $207K | ﹤0.01% |
+3,972
| New | +$211K |
|
780
Ingredion
INGR
$6.27B
| $207K | ﹤0.01% |
3,026
-100,257
| -97% | -$6.58M |
|
781
Middleby
MIDD
$6.04B
| $207K | ﹤0.01% |
2,340
-9,288
| -80% | -$810K |
|
782
Olin
OLN
$2.11B
| $207K | ﹤0.01% |
7,465
-2,838
| -28% | -$76.5K |
|
783
Synopsys
SNPS
$74.4B
| $207K | ﹤0.01% |
+5,387
| New | +$216K |
|
|
MINI
784
DELISTED
Mobile Mini Inc
MINI
| $207K | ﹤0.01% |
+4,771
| New | +$199K |
|
|
CYN
785
DELISTED
CITY NATIONAL CORPORATION
CYN
| $207K | ﹤0.01% |
+2,627
| New | +$198K |
|
786
Clorox
CLX
$11.6B
| $206K | ﹤0.01% |
2,331
-12,161
| -84% | -$1.07M |
|
787
Columbia Sportswear
COLM
$3.04B
| $205K | ﹤0.01% |
+4,944
| New | +$197K |
|
|
GES
788
DELISTED
Guess Inc
GES
| $205K | ﹤0.01% |
7,412
+705
| +11% | +$20.5K |
|
789
Home Depot
HD
$331B
| $205K | ﹤0.01% |
+2,590
| New | +$206K |
|
790
Pricesmart
PSMT
$5.98B
| $205K | ﹤0.01% |
+2,024
| New | +$203K |
|
|
ONIT
791
Onity Group
ONIT
$309M
| $205K | ﹤0.01% |
348
+85
| +32% | +$55.1K |
|
|
SBNY
792
DELISTED
Signature Bank
SBNY
| $205K | ﹤0.01% |
1,632
-24,354
| -94% | -$2.97M |
|
793
American Financial Group
AFG
$11.8B
| $204K | ﹤0.01% |
+3,532
| New | +$199K |
|
|
HI
794
DELISTED
Hillenbrand
HI
| $204K | ﹤0.01% |
+6,306
| New | +$187K |
|
795
Microchip Technology
MCHP
$40.3B
| $204K | ﹤0.01% |
8,514
-3,520
| -29% | -$80.4K |
|
796
Mondelez International
MDLZ
$79.5B
| $204K | ﹤0.01% |
5,895
-135,055
| -96% | -$4.62M |
|
797
ON Semiconductor
ON
$31.8B
| $204K | ﹤0.01% |
21,694
+5,656
| +35% | +$50.8K |
|
798
State Street
STT
$50.6B
| $204K | ﹤0.01% |
2,930
-4,387
| -60% | -$303K |
|
799
Viatris
VTRS
$20.4B
| $204K | ﹤0.01% |
4,174
-14,055
| -77% | -$682K |
|
|
CPN
800
DELISTED
Calpine Corporation
CPN
| $204K | ﹤0.01% |
9,726
-2,261
| -19% | -$44.3K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.